GTBP
GT Biopharma Inc
NASDAQ: GTBP · HEALTHCARE · BIOTECHNOLOGY
$0.31
+13.31% today
Updated 2026-04-30
Market cap
$8.83M
P/E ratio
—
P/S ratio
204.96x
EPS (TTM)
$-6.68
Dividend yield
—
52W range
$0 – $4
Volume
0.7M
GT Biopharma Inc (GTBP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.78M | $6.05M | $1.14M | $48000.00 | $11000.00 | $26000.00 | $342000.00 | $368000.00 | $61000.00 | $27000.00 | $0.00 | $27000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +4.7% | -81.1% | -95.8% | -77.1% | +136.4% | +1215.4% | +7.6% | -83.4% | -55.7% | -100.0% | — | -100.0% | — | — | — | — | — | — | — |
| Cost of revenue | $3.08M | $3.26M | $909000.00 | $50000.00 | $65000.00 | $48000.00 | $94000.00 | $226000.00 | $57000.00 | $2000.00 | $1000.00 | $2000.00 | $7000.00 | $4000.00 | — | — | — | — | — | — |
| Gross profit | $2.69M | $2.79M | $234000.00 | $-2000.00 | $-54000.00 | $-22000.00 | $248000.00 | $142000.00 | $4000.00 | $25000.00 | $-1000.00 | $-2000.00 | $-7000.00 | $-4000.00 | — | — | — | — | — | — |
| Gross margin | 46.6% | 46.1% | 20.5% | -4.2% | -490.9% | -84.6% | 72.5% | 38.6% | 6.6% | 92.6% | — | -7.4% | — | — | — | — | — | — | — | — |
| R&D | $708000.00 | $1.04M | $44000.00 | $44000.00 | $179000.00 | $17000.00 | — | — | $1.00M | $1.00M | $975000.00 | $1.07M | $9.07M | $1.67M | $485000.00 | $9.59M | $8.81M | $6.47M | $5.80M | $3.47M |
| SG&A | $5.36M | $3.75M | $1.45M | $1.15M | $2.26M | $3.47M | $3.36M | $935000.00 | $935000.00 | $7.95M | $8.40M | $134.50M | $12.49M | $9.79M | $6.28M | $47.92M | $12.45M | $8.23M | $8.57M | $8.95M |
| Operating income | $-2.67M | $-1.12M | $-1.21M | $-1.16M | $-2.50M | $-3.93M | $-3.51M | $-793000.00 | $-2.40M | $-8.93M | $-9.37M | $-135.57M | $-250.07M | $-11.46M | $-6.76M | $-57.52M | $-21.26M | $-13.58M | $-14.36M | $-12.42M |
| Operating margin | -46.2% | -18.4% | -105.9% | -2408.3% | -22700.0% | -15107.7% | -1027.5% | -215.5% | -3927.9% | -33063.0% | — | -502111.1% | — | — | — | — | — | — | — | — |
| EBITDA | $-2.37M | $-223000.00 | $-3.02M | $-1.05M | $-2.45M | $-3.12M | $-3.51M | $-791000.00 | $-2.37M | $-8.93M | $-9.37M | $-135.57M | $-250.06M | $-36.52M | $-24.97M | $-57.48M | $-20.96M | $5.98M | $-13.16M | $-34.32M |
| EBITDA margin | -41.0% | -3.7% | -264.3% | -2197.9% | -22281.8% | -12003.8% | -1026.6% | -214.9% | -3891.8% | -33055.6% | — | -502103.7% | — | — | — | — | — | — | — | — |
| EBIT | $-2.67M | $-1.12M | $-3.27M | $-1.11M | $-2.48M | $-3.14M | $-3.51M | $-793000.00 | $-2.40M | $-8.93M | $-9.37M | $-135.57M | $-250.07M | $-36.52M | $-24.98M | $-114.99M | $-42.22M | $-7.60M | $-27.53M | — |
| Interest expense | $2.16M | $1.01M | $0.00 | $1.14M | $513000.00 | $556000.00 | $0.00 | $0.00 | $5.15M | $17.04M | $6.55M | $8.60M | $9.12M | $2.13M | $3.32M | $718000.00 | $8000.00 | $213000.00 | $0.00 | $127000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.94M | $471000.00 | $-5.01M | $-2.25M | $-3.00M | $-3.70M | $-5.17M | $-501000.00 | $-23.49M | $-21.46M | $9.77M | $-144.17M | $-259.19M | $-38.65M | $-28.30M | $-58.01M | $-20.88M | $-7.60M | $-13.16M | $-28.35M |
| Net income growth (YoY) | — | +109.5% | -1162.8% | +55.1% | -33.3% | -23.5% | -39.8% | +90.3% | -4588.4% | +8.6% | +145.5% | -1576.0% | -79.8% | +85.1% | +26.8% | -105.0% | +64.0% | +63.6% | -73.3% | -115.4% |
| Profit margin | -85.5% | 7.8% | -438.0% | -4679.2% | -27227.3% | -14230.8% | -1512.0% | -136.1% | -38506.6% | -79485.2% | — | -533970.4% | — | — | — | — | — | — | — | — |